Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience: Patrick Weiss, Bill Banyai

Twist Bioscience has promoted Patrick Weiss to chief operating officer from senior VP of R&D and general manager of data storage. It has appointed Bill Banyai as senior VP of advanced development and general manager of data storage.

Before helping to build Twist's operational infrastructure, Weiss served as President and CEO of Operon Biotechnologies. He also founded Xeragon, an RNA synthesis and bioinformatics firm acquired by Qiagen in 2002. He holds a master's degree in chemistry from the Swiss Federal Institute of Technology and is an author on several patents.

Banyai is a cofounder and director of the company and will maintain his board seat. He led the integration of Genome Compiler, which Twist acquired in 2016 and has overseen facilities expansions. Banyai previously served as VP of hardware at Complete Genomics. He holds a doctorate in optical science from the University of Arizona.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.